Skip to main content
. 2021 Sep 24;12:759267. doi: 10.3389/fphar.2021.759267

FIGURE 8.

FIGURE 8

LINC01001 overexpression increases crizotinib-resistance of NSCLC cells via MYC. (A) RT-qPCR and western blot detected the level of MYC. (B) CCK-8 assay assessed the viability of crizotinib-resistant NSCLC cells. (C) EdU assay evaluated the proliferation of crizotinib-resistant NSCLC cells. (D) Western blot examined the level of proliferation-related proteins. E, FACs detected apoptosis of crizotinib-resistant NSCLC cells. F, TUNEL assessed apoptosis of crizotinib-resistant NSCLC cells. **p < 0.01, ***p < 0.001 vs NC group, #p < 0.05, ##p < 0.01, ###p < 0.001 vs LINC01001+sh-NC group. Error bars represent SD. Data represent three independent experiments.